V
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches. Headquartered in San Diego, CA, Vical is independently pioneering the development of paradigm-changing therapies, and is partnering with key industry leaders. Additional information on Vical is available at www.vical.com.
Investor insights
Funding rounds participated in
$25M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology
Sectors
Biotechnology
Date founded
1987
Funding rounds raised
Total raised
$25M
from investors over 1 rounds
V
Vical raised $25M on December 8, 2017